Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Markets
Screener
News
About

VCEL - Vericel Corporation Latest News | Finranks

Home

VCEL

(VCEL)

NGM – Real Time Price. Currency in USD

29.34

-1.48 (-4.80%)

At close: Mar 27, 2026, 4:00 PM EDT

28.60

-0.74 (-2.52%)

After-hours: Mar 27, 2026, 4:43 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Vericel Corporation (VCEL) Matches Q4 Earnings Estimates

Vericel Corporation (VCEL) Matches Q4 Earnings Estimates

Vericel Corporation (VCEL) came out with quarterly earnings of $0.45 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.38 per share a year ago.

Vericel Corporation (VCEL) Q4 2025 Earnings Call Transcript

Vericel Corporation (VCEL) Q4 2025 Earnings Call Transcript

Vericel Corporation (VCEL) Q4 2025 Earnings Call Transcript

Vericel Reports Fourth Quarter and Full-Year 2025 Financial Results

Vericel Reports Fourth Quarter and Full-Year 2025 Financial Results

Total Revenue of $276.3 Million, with MACI Revenue Growth of 21% to $239.5 Million Net Income Growth of 59% to $16.5 Million Fourth Quarter Total Revenue and MACI Revenue Growth of 23% Record Fourth Quarter Gross Margin of 79% and Adjusted EBITDA Margin of 40% Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today reported financial results and business highlights for the fourth quarter and year ended December 31, 2025.

Madison Small Cap Fund Q4 2025: Buys, Sells, And Standouts

Madison Small Cap Fund Q4 2025: Buys, Sells, And Standouts

In the fourth quarter we sold four stocks (WAL, CFLT, CCOI, CIEN) and added six new investments (MIR, VCEL, AMPL, VIAV, GTLB, AAON). We exited our investment in infrastructure software vendor CFLT following the announcement that IBM would acquire the company for $11 billion, or $31 per share. We initiated a new investment position in GitLab (GTLB), a Dev/Sec/Ops software platform vendor that helps software developers plan, build, and monitor code.

These under-the-radar stocks combine fast growth with big upside potential

These under-the-radar stocks combine fast growth with big upside potential

The companies are projected to grow sales rapidly through 2027, and many of the stocks are expected to show double-digit increases this year.

Vericel Corporation (VCEL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Vericel Corporation (VCEL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Vericel Corporation (VCEL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Vericel Announces Preliminary 2025 Financial Results and Business Updates

Vericel Announces Preliminary 2025 Financial Results and Business Updates

Total Revenue Expected to be $276 Million MACI Revenue Expected to be $239.5 Million Fourth Quarter Total Revenue and MACI Revenue Growth of 23% CAMBRIDGE, Mass., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced preliminary, unaudited financial results and other business updates for the fourth quarter and year ended December 31, 2025.

Videos

No Data

There is no data to display